Next Generation Natural Killer Cells for Cancer Immunotherapy

In recent years, immunotherapy for cancer has become mainstream with several products now authorized for therapeutic use in the clinic and are becoming the standard of care for some malignancies. Chimeric antigen receptor (CAR)-T cell therapies have demonstrated substantial efficacy for the treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossi, Fiorella, Fredericks, Nathaniel, Snowden, Andrew, Allegrezza, Michael J., Moreno-Nieves, Uriel Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202478/
https://www.ncbi.nlm.nih.gov/pubmed/35720306
http://dx.doi.org/10.3389/fimmu.2022.886429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202478/
https://www.ncbi.nlm.nih.gov/pubmed/35720306
http://dx.doi.org/10.3389/fimmu.2022.886429

Ejemplares similares